A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Panelists discuss the expanding array of treatment options for metastatic hormone receptor–positive breast cancer, emphasizing the critical role of molecular testing—both tissue biopsy and circulating ...

Mutation: process of changing in form or nature. We publish the best academic journals & first hand accounts of Mutation ...

Akriti Jain, MD, discussed how emerging data on non-ABL1 mutations is reshaping chronic myeloid leukemia management. While the management of chronic myeloid leukemia (CML) has evolved significantly ...

Abstract: This paper presents intent-based mutation testing, a testing approach that generates mutations by changing the programming intents that are implemented in the programs under test. In ...

Mutation testing evaluates test quality by deliberately introducing small code changes ("mutations") and seeing if your tests catch them. It's essentially the process of systematically and purposely ...

Significant variability exists in genetic/genomic testing practices for mCRPC across different regions, with 50% of patients recommended for HRR mutation testing. Testing recommendations increased ...

Using AI, we identified publications that likely reported a testing or mutation rate, filtered publications for cancer type, and identified sentences that likely reported rates. Rates and covariates ...

Integrating HER2-directed therapies into NSCLC decision-making requires adapting protocols and ensuring timely updates as new therapies emerge. Streamlined processes and enhanced communication among ...

NEW YORK (Reuters) - Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the pharmaceutical maker anticipates ...